-
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
02 Apr 2025 20:05 GMT
… ® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE:
Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS … .09
)
$
(26.75
)
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED BALANCE SHEET
(In …
-
Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock
24 Mar 2025 11:30 GMT
… 24, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ … legal counsel to Cyclacel. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical …
-
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership
27 Feb 2025 18:38 GMT
… . 27, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel") (NASDAQ … counsel to David Lazar. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical …
-
Top movers in Tuesday's pre-market session
29 Apr 2025 16:09 GMT
… .25%
The stock price of CYCLACEL PHARMACEUTICALS INC (NASDAQ:CYCC) is declining …
-
Why Cyclacel Pharmaceuticals (CYCC) Stock Is Skyrocketing
03 Jan 2025 15:31 GMT
Cyclacel Pharmaceuticals Inc CYCC shares are trading … other instrument.
For example, in Cyclacel Pharmaceuticals’ case, it is in the …
-
Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
03 Jan 2025 14:01 GMT
… . 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … risks described more fully in Cyclacel Pharmaceuticals’ filings with the Securities … IR@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs
05 Dec 2024 21:05 GMT
… . 05, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … risks described more fully in Cyclacel Pharmaceuticals’ filings with the Securities … IR@cyclacel.com © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds
14 Nov 2024 21:15 GMT
… . 14, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … state or other jurisdiction. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a … IR@cyclacel.com © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds
13 Nov 2024 17:22 GMT
… . 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … state or other jurisdiction. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a … IR@cyclacel.com © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
12 Nov 2024 21:45 GMT
… or otherwise. Contacts © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The … Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc.
CYCLACEL PHARMACEUTICALS, INC.
CONSOLIDATED STATEMENTS …
About
© 1995-2025